Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-04-10 @ 8:41 PM
Study NCT ID:
NCT00048295
Status:
COMPLETED
Last Update Posted:
2022-08-15
First Post:
2002-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ISIS 2302-CS21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None